A substantial proportion of the broadly neutralizing antibodies (bnAbs) identified in certain HIV-infected donors recognize glycan-dependent epitopes on HIV-1 gp120. Here we elucidate how the bnAb PGT 135 binds its Asn332 glycan-dependent epitope from its 3.1-Å crystal structure with gp120, CD4 and Fab 17b. PGT 135 interacts with glycans at Asn332, Asn392 and Asn386, using long CDR loops H1 and H3 to penetrate the glycan shield and access the gp120 protein surface. EM reveals that PGT 135 can accommodate the conformational and chemical diversity of gp120 glycans by altering its angle of engagement. Combined structural studies of PGT 135, PGT 128 and 2G12 show that this Asn332-dependent antigenic region is highly accessible and much more ext...
International audienceBroadly neutralizing antibodies (bnAbs) directed against the mannose-patch on ...
International audienceBroadly neutralizing antibodies (bnAbs) directed against the mannose-patch on ...
Broadly neutralizing antibodies have been isolated that bind the glycan shield of the HIV-1 envelope...
A substantial proportion of the broadly neutralizing antibodies (bnAbs) identified in certain HIV-in...
The HIV envelope (Env) protein gp120 is protected from antibody recognition by a dense glycan shield...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...
<div><p>New broad and potent neutralizing HIV-1 antibodies have recently been described that are lar...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccin...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccin...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccin...
New broad and potent neutralizing HIV-1 antibodies have recently been described that are largely dep...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccin...
Broadly neutralizing HIV antibodies (bNAbs) can recognize carbohydrate-dependent epitopes on gp120. ...
International audienceBroadly neutralizing antibodies (bnAbs) directed against the mannose-patch on ...
International audienceBroadly neutralizing antibodies (bnAbs) directed against the mannose-patch on ...
International audienceBroadly neutralizing antibodies (bnAbs) directed against the mannose-patch on ...
Broadly neutralizing antibodies have been isolated that bind the glycan shield of the HIV-1 envelope...
A substantial proportion of the broadly neutralizing antibodies (bnAbs) identified in certain HIV-in...
The HIV envelope (Env) protein gp120 is protected from antibody recognition by a dense glycan shield...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...
Broadly neutralizing antibodies (bNAbs) to HIV-1 envelope glycoprotein (Env) can prevent infection i...
<div><p>New broad and potent neutralizing HIV-1 antibodies have recently been described that are lar...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccin...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccin...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccin...
New broad and potent neutralizing HIV-1 antibodies have recently been described that are largely dep...
Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccin...
Broadly neutralizing HIV antibodies (bNAbs) can recognize carbohydrate-dependent epitopes on gp120. ...
International audienceBroadly neutralizing antibodies (bnAbs) directed against the mannose-patch on ...
International audienceBroadly neutralizing antibodies (bnAbs) directed against the mannose-patch on ...
International audienceBroadly neutralizing antibodies (bnAbs) directed against the mannose-patch on ...
Broadly neutralizing antibodies have been isolated that bind the glycan shield of the HIV-1 envelope...